Stroke in a child with hemoglobin SC disease: A case report describing use of hydroxyurea after transfusion therapy

Diana Fridlyand, Caroline Wilder, E. Leila Jerome Clay, Bruce Gilbert, Betty S. Pace

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Children with hemoglobin SC (HbSC) disease suffer a significant incidence of silent cerebral infarcts but stroke is rare. A 2-year-old African American boy with HbSC disease presented with focal neurologic deficits associated with magnetic resonance imaging evidence of cerebral infarction with vascular abnormalities. After the acute episode he was treated with monthly transfusions and subsequently transitioned to hydroxyurea therapy. The benefits of hydroxyurea as a fetal hemoglobin inducer in HbSC disease, to ameliorate clinical symptoms are supported by retrospective studies. This case highlights the rare occurrence of stroke in a child with HbSC disease and the use of hydroxyurea therapy.

Original languageEnglish (US)
Article number6984
JournalPediatric Reports
Volume9
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Hemoglobin SC Disease
Hydroxyurea
Stroke
Fetal Hemoglobin
Cerebral Infarction
Therapeutics
Neurologic Manifestations
African Americans
Blood Vessels
Retrospective Studies
Magnetic Resonance Imaging
Incidence

Keywords

  • Cerebral infarct
  • Hematology
  • Hemoglobin SC disease
  • Hydroxyurea
  • Sickle cell anemia

ASJC Scopus subject areas

  • Pediatrics

Cite this

Stroke in a child with hemoglobin SC disease : A case report describing use of hydroxyurea after transfusion therapy. / Fridlyand, Diana; Wilder, Caroline; Clay, E. Leila Jerome; Gilbert, Bruce; Pace, Betty S.

In: Pediatric Reports, Vol. 9, No. 1, 6984, 01.01.2017.

Research output: Contribution to journalArticle

@article{9daf9e155236480eb5b6742c00cdabc8,
title = "Stroke in a child with hemoglobin SC disease: A case report describing use of hydroxyurea after transfusion therapy",
abstract = "Children with hemoglobin SC (HbSC) disease suffer a significant incidence of silent cerebral infarcts but stroke is rare. A 2-year-old African American boy with HbSC disease presented with focal neurologic deficits associated with magnetic resonance imaging evidence of cerebral infarction with vascular abnormalities. After the acute episode he was treated with monthly transfusions and subsequently transitioned to hydroxyurea therapy. The benefits of hydroxyurea as a fetal hemoglobin inducer in HbSC disease, to ameliorate clinical symptoms are supported by retrospective studies. This case highlights the rare occurrence of stroke in a child with HbSC disease and the use of hydroxyurea therapy.",
keywords = "Cerebral infarct, Hematology, Hemoglobin SC disease, Hydroxyurea, Sickle cell anemia",
author = "Diana Fridlyand and Caroline Wilder and Clay, {E. Leila Jerome} and Bruce Gilbert and Pace, {Betty S.}",
year = "2017",
month = "1",
day = "1",
doi = "10.4081/pr.2017.6984",
language = "English (US)",
volume = "9",
journal = "Pediatric Reports",
issn = "2036-749X",
publisher = "PagePress",
number = "1",

}

TY - JOUR

T1 - Stroke in a child with hemoglobin SC disease

T2 - A case report describing use of hydroxyurea after transfusion therapy

AU - Fridlyand, Diana

AU - Wilder, Caroline

AU - Clay, E. Leila Jerome

AU - Gilbert, Bruce

AU - Pace, Betty S.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Children with hemoglobin SC (HbSC) disease suffer a significant incidence of silent cerebral infarcts but stroke is rare. A 2-year-old African American boy with HbSC disease presented with focal neurologic deficits associated with magnetic resonance imaging evidence of cerebral infarction with vascular abnormalities. After the acute episode he was treated with monthly transfusions and subsequently transitioned to hydroxyurea therapy. The benefits of hydroxyurea as a fetal hemoglobin inducer in HbSC disease, to ameliorate clinical symptoms are supported by retrospective studies. This case highlights the rare occurrence of stroke in a child with HbSC disease and the use of hydroxyurea therapy.

AB - Children with hemoglobin SC (HbSC) disease suffer a significant incidence of silent cerebral infarcts but stroke is rare. A 2-year-old African American boy with HbSC disease presented with focal neurologic deficits associated with magnetic resonance imaging evidence of cerebral infarction with vascular abnormalities. After the acute episode he was treated with monthly transfusions and subsequently transitioned to hydroxyurea therapy. The benefits of hydroxyurea as a fetal hemoglobin inducer in HbSC disease, to ameliorate clinical symptoms are supported by retrospective studies. This case highlights the rare occurrence of stroke in a child with HbSC disease and the use of hydroxyurea therapy.

KW - Cerebral infarct

KW - Hematology

KW - Hemoglobin SC disease

KW - Hydroxyurea

KW - Sickle cell anemia

UR - http://www.scopus.com/inward/record.url?scp=85016454673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016454673&partnerID=8YFLogxK

U2 - 10.4081/pr.2017.6984

DO - 10.4081/pr.2017.6984

M3 - Article

AN - SCOPUS:85016454673

VL - 9

JO - Pediatric Reports

JF - Pediatric Reports

SN - 2036-749X

IS - 1

M1 - 6984

ER -